Medtronic Starts Next-Gen Drug-Eluting Stent Trials

The company is initially targeting very small vessels in a new pivotal study for its Resolute Onyx zotarolimus-eluting stent. Medtronic is separately launching a study of its novel "drug-filled" stent platform.